Literature DB >> 33454881

Multimodality Therapy in Operable Pancreatic Cancer: Should We Sequence Surgery Last?

Jashodeep Datta1, Nipun B Merchant2.   

Abstract

Entities:  

Year:  2021        PMID： 33454881     DOI： 10.1245/s10434-020-09400-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  2 in total

1.  Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.

Authors:  Jashodeep Datta; Raja R Narayan; Debra A Goldman; Walid K Chatila; Mithat Gonen; James Strong; Vinod P Balachandran; Jeffrey A Drebin; T Peter Kingham; William R Jarnagin; Nikolaus Schultz; Nancy E Kemeny; Michael I D'Angelica
Journal:  Ann Surg       Date:  2020-11-17       Impact factor: 13.787

2.  Direct Comparison of In-Person Versus Virtual Interviews for Complex General Surgical Oncology Fellowship in the COVID-19 Era.

Authors:  Monica M Grova; Sean J Donohue; Michael O Meyers; Hong Jin Kim; David W Ollila
Journal:  Ann Surg Oncol       Date:  2020-11-26       Impact factor: 5.344
  2 in total
  1 in total

1.  Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study.

Authors:  Iago de Castro Silva; Anna Bianchi; Nilesh U Deshpande; Prateek Sharma; Siddharth Mehra; Vanessa Tonin Garrido; Shannon Jacqueline Saigh; Jonathan England; Peter Joel Hosein; Deukwoo Kwon; Nipun B Merchant; Jashodeep Datta
Journal:  Elife       Date:  2022-09-15       Impact factor: 8.713
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.